日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Biodistribution of free Francium-221 and Bismuth-213 in Tumour-bearing SCID mice after successful development of Actinium-225/Francium-221 radionuclide generator Set-up

在成功建立锕-225/钫-221放射性核素发生器装置后，肿瘤SCID小鼠体内游离钫-221和铋-213的生物分布

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-025-07427-4
Zitzmann-Kolbe, Sabine; Remde, Yvonne; Moen, Ingrid; Madas, Balázs; Mázik, László; Suurs, Frans; Happel, Steffen; Schäfer, Martin; Schatz, Christoph; Taş, Harun; Hagemann, Urs B; Benešová-Schäfer, Martina
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Mono- and multimeric PSMA-targeting small molecule-thorium-227 conjugates for optimized efficacy and biodistribution in preclinical models

单体和多聚体PSMA靶向小分子-钍-227偶联物在临床前模型中优化疗效和生物分布

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-023-06474-z
Böhnke, Niels; Indrevoll, Bård; Hammer, Stefanie; Papple, Alex; Kristian, Alexander; Briem, Hans; Celik, Arif; Mumberg, Dominik; Cuthbertson, Alan; Zitzmann-Kolbe, Sabine
发表日期：2024
文献求助 收藏

A Targeted Thorium-227 Conjugate Demonstrates Efficacy in Preclinical Models of Acquired Drug Resistance and Combination Potential with Chemotherapeutics and Antiangiogenic Therapies.

靶向钍-227偶联物在获得性耐药的临床前模型中显示出疗效，并具有与化疗药物和抗血管生成疗法联合应用的潜力

期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-22-0808
Zitzmann-Kolbe Sabine, Kristian Alexander, Zopf Dieter, Kamfenkel Claudia, Politz Oliver, Ellingsen Christine, Hilbig Jochen, Juul Mark U, Fonslet Jesper, Nielsen Carsten H, Schatz Christoph A, Bjerke Roger M, Cuthbertson Alan S, Mumberg Dominik, Hagemann Urs B
心血管
血管生成
发表日期：2023
文献求助 收藏

Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy

靶向钍-227偶联物作为单药及与抗PD-L1疗法联合应用时的免疫刺激作用

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2021-002387
Lejeune, Pascale; Cruciani, Véronique; Berg-Larsen, Axel; Schlicker, Andreas; Mobergslien, Anne; Bartnitzky, Lisa; Berndt, Sandra; Zitzmann-Kolbe, Sabine; Kamfenkel, Claudia; Stargard, Stefan; Hammer, Stefanie; Jørgensen, Jennifer S; Jackerott, Malene; Nielsen, Carsten H; Schatz, Christoph A; Hennekes, Hartwig; Karlsson, Jenny; Cuthbertson, Alan S; Mumberg, Dominik; Hagemann, Urs B
PD-L1
免疫/内分泌
发表日期：2021
文献求助 收藏

Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy

精准肿瘤学进展：靶向钍-227偶联物作为靶向α疗法的新模式

期刊:Cancer Biotherapy and Radiopharmaceuticals
影响因子:2.1
doi:10.1089/cbr.2020.3568
Hagemann, Urs B; Wickstroem, Katrine; Hammer, Stefanie; Bjerke, Roger M; Zitzmann-Kolbe, Sabine; Ryan, Olav B; Karlsson, Jenny; Scholz, Arne; Hennekes, Hartwig; Mumberg, Dominik; Cuthbertson, Alan S
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models

Anetumab ravtansine 可抑制肿瘤生长，并且在表达间皮素的人类卵巢癌模型中与靶向药物和化疗联合使用时显示出叠加效应。

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.26135
Quanz, Maria; Hagemann, Urs B; Zitzmann-Kolbe, Sabine; Stelte-Ludwig, Beatrix; Golfier, Sven; Elbi, Cem; Mumberg, Dominik; Ziegelbauer, Karl; Schatz, Christoph A
肿瘤
肿瘤免疫
卵巢癌
发表日期：2018
文献求助 收藏